PMID: 7019157Jun 1, 1981Paper

Levamisole: potentiation of primary immunoglobulin M antibody responses in suckling rats

Immunopharmacology
K W HunterG T Strickland

Abstract

The influence of levamisole (LMS) on the primary immunoglobulin M (IgM antibody response of suckling rats was investigated. Although suckling rats did make a direct plaque-forming cell (PFC) response to sheep red blood cells (SRBC), the magnitude of this response was much lower than that of adult rats. LMS treatment (2.5 mg/kg) markedly potentiated the anti-SRBC response in 10-day-old rats, but this enhanced PFC response never attained adult levels. In contrast, LMS failed to boost the anti-SRBC response of adult rats, although the adult response to suboptimal antigenic stimuli was enhanced. The ontogeny of immunological responsiveness to SRBC was not influenced by LMS; only existing responses could be modulated. The potentiating effect of LMS was dose-dependent, with high doses causing suppression. The influence of LMS did not involve the earlier appearance of PFC. Since LMS augmented the PFC response to SRBC when administered before or after antigen, it appears that both the inductive phase and the proliferative phase of antibody production can be modulated. Finally, the PFC responses to a more thymus-independent antigen (2,4,6-trinitrophenyl-Ficoll) was boosted, suggesting that LMS may be capable of directly influencing B ly...Continue Reading

References

Nov 1, 1975·The Journal of Infectious Diseases·G W FischerG Y Kobayaski
Jan 1, 1979·International Journal of Immunopharmacology·A CruchaudH D Welscher
Jan 1, 1979·International Archives of Allergy and Applied Immunology·T OgitaY Mizushima
Jan 1, 1979·International Journal of Immunopharmacology·G RenouxJ M Guillaumin
Jan 1, 1979·Immunological Communications·J V FaheyF S Szmalc
Aug 1, 1975·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A Mantovani, F Spreafico
Aug 1, 1975·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F SpreaficoS Garattini
Dec 1, 1973·The Journal of Infectious Diseases·I GoldschneiderM Randolph
Nov 1, 1969·Proceedings of the Society for Experimental Biology and Medicine·M B Rittenberg, K L Pratt

❮ Previous
Next ❯

Citations

Oct 1, 1993·Alcoholism, Clinical and Experimental Research·W M StevenL L Seelig
Sep 1, 1983·Infection and Immunity·R J GudvangenC J Gauntt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.